We found 11 online brokers that are appropriate for Trading Pharmaceutical Shares Trading Platform.
When pharmaceutical shares are mentioned, traders may immediately assume that this sector will perform rather well in the near future, as people have become more health-conscious since the Corona pandemic.
Investing in pharmaceutical shares will become a popular trend in the coming months amid the economic and political instability in most parts of the world. Currently, the pharma companies are high in demand for their health equipment and products. This, in turn, is increasing the value of their shares.
In this article, titled 'Pharmaceutical Shares', we will talk about some of the stocks having the highest market capitalizations and the best dividend yield percentages as well.
Investors tend to perceive the value of pharma companies based on the price of pharmaceutical shares. This is further reciprocated by the profit or loss made by a trader after opening a trade. This is the reason one needs to analyze the fundamentals of a company before buying its shares. Analyzing should, in fact, be a necessary precaution before opening a long-term position.
The easiest way to value the shares of a company is by taking a look at the price-to-earnings ratios (P/E ratio) against its competitors.
Investors usually seek shares that have the potential for growth and earnings, and companies that are paying constant dividends. In fact, dividend payments strengthen loyalty.
Pharma penny stocks have gained popularity in recent months, especially during the Corona pandemic when the race to develop a vaccine is ongoing. Penny stocks, like those of 'Pharma Mar' and 'Inovio Pharmaceuticals' have jumped up several folds.
Traded as GSK, the global pharma firm manufactures and markets medicines, vaccines, and other related products. The stock of this London-headquartered company is considered as low-risk and better for diversifying risk portfolios. The current market capitalization of GlaxoSmithKline is $105 billion, and its P/E ratio is 15.43.
The company has an RnD existence in the United States, the United Kingdom, and Sweden. It mainly focuses on developing prescription medicine for auto-immunity, respiratory, and cardiovascular ailments. Following the Corona pandemic, its stocks became one of the fastest-growing. In recent months, its share prices have increased sharply. The current market capitalization of AstraZeneca is $142 billion, and the P/E ratio is 91.7.
Traded as GILD, the United States-based biopharmaceutical company produces anti-viral solutions for liver, HIV, and some inflammatory diseases like influenza. In early 2020, the share prices of Gilead Sciences jumped following the announcement that it is one of the primary contenders in the race for developing a Corona vaccine. Its current market capitalization is $94.5 billion, and the P/E ratio is 19.37.
Being a spin-off of Abbott Laboratories, AbbVie focuses mainly on the treatment of chronic auto-immune diseases like blood cancer. Last year, the company acquired Ireland-based Allergan which resulted in a rise in share price. It has a good name among investors for paying constant dividends. Its current market capitalization is $136 billion, and its P/E ratio is 16.27.
The United States-based vaccine developer is a small-cap pharma stock with a smaller presence in the healthcare sector. Novavax has seen fast-paced developments in the clinical testing period for a Corona vaccine. This has resulted in an increase in the value of its shares by 2x since the beginning of 2020. Its current market capitalization is $2.58 billion.
Even though the company is growing, it should be noted that it does not pay dividends.
Traded as PFE, it is one of the largest pharmaceutical companies in the world. It was founded in 1849, and is headquartered in New York City. Currently, Pfizer stocks are one of the most popular biotech stocks. The company mainly develops and distributes vaccines and medicines for immunology and inflammatory diseases. It has a market capitalization of $200 billion, and the P/E ratio is 12.85.
The British pharma company focuses on the treatment of multiple sclerosis. It is involved in the production of medical marijuana. It is best known for its high-value stock price. Its market capitalization is $3.92 billion, and the P/E ratio is 129.46.
Traded as SNY, the Paris-based company deals in therapeutics like arthritis, cancers, and multiple sclerosis. Sanofi has a market capitalization of $125 billion, and its P/E ratio is 15.94.
It is true that people across the world are now more conscious about their health than they were before the Corona pandemic began. This consciousness is a boom for the pharma industry, and share prices of the pharmaceutical companies are more than likely going to jump several folds in the next few months, or even in the next year. However, investors are suggested to study the company before buying its shares. It is important to check whether the company is paying constant dividends, and that the shares have the potentiality of growth even after the pandemic ends.
We have conducted extensive research and analysis on over multiple data points on Pharmaceutical Shares to present you with a comprehensive guide that can help you find the most suitable Pharmaceutical Shares. Below we shortlist what we think are the best Pharmaceutical shares trading platform after careful consideration and evaluation. We hope this list will assist you in making an informed decision when researching Pharmaceutical Shares.
Selecting a reliable and reputable online Pharmaceutical Shares Trading Platform trading brokerage involves assessing their track record, regulatory status, customer support, processing times, international presence, and language capabilities. Considering these factors, you can make an informed decision and trade Pharmaceutical Shares Trading Platform more confidently.
Selecting the right online Pharmaceutical Shares Trading Platform trading brokerage requires careful consideration of several critical factors. Here are some essential points to keep in mind:
Our team have listed brokers that match your criteria for you below. All brokerage data has been summarised into a comparison table. Scroll down.
When choosing a broker for Pharmaceutical shares trading platform trading, it's essential to compare the different options available to you. Our Pharmaceutical shares trading platform brokerage comparison table below allows you to compare several important features side by side, making it easier to make an informed choice.
By comparing these essential features, you can choose a Pharmaceutical shares trading platform broker that best suits your needs and preferences for Pharmaceutical shares trading platform. Our Pharmaceutical shares trading platform broker comparison table simplifies the process, allowing you to make a more informed decision.
Here are the top Pharmaceutical Shares Trading Platform.
Compare Pharmaceutical shares trading platform brokers for min deposits, funding, used by, benefits, account types, platforms, and support levels. When searching for a Pharmaceutical shares trading platform broker, it's crucial to compare several factors to choose the right one for your Pharmaceutical shares trading platform needs. Our comparison tool allows you to compare the essential features side by side.
All brokers below are Pharmaceutical shares trading platform. Learn more about what they offer below.
You can scroll left and right on the comparison table below to see more Pharmaceutical shares trading platform that accept Pharmaceutical shares trading platform clients.
Broker | IC Markets | Roboforex | eToro | XTB | XM | Pepperstone | AvaTrade | FP Markets | EasyMarkets | SpreadEx | FXPro |
---|---|---|---|---|---|---|---|---|---|---|---|
Rating | |||||||||||
Regulation | Australian Securities and Investments Commission (ASIC), Financial Services Authority (FSA), Cyprus Securities and Exchange Commission (CySEC) | RoboForex Ltd is regulated by the FSC, license 000138/437, reg. number 128.572. RoboForex Ltd, which is an (A category) member of The Financial Commission, also is a participant of its Compensation Fund | FCA (Financial Conduct Authority) eToro (UK) Ltd (FCA reference 583263), eToro (Europe) Ltd CySEC (Cyprus Securities Exchange Commission), ASIC (Australian Securities and Investments Commission) eToro AUS Capital Limited ASIC license 491139, CySec (Cyprus Securities and Exchange Commission under the license 109/10), FSAS (Financial Services Authority Seychelles) eToro (Seychelles) Ltd license SD076 | FCA (Financial Conduct Authority reference 522157), CySEC (Cyprus Securities and Exchange Commission reference 169/12), FSCA (Financial Sector Conduct Authority), XTB AFRICA (PTY) LTD licensed to operate in South Africa, KPWiG (Polish Securities and Exchange Commission), DFSA (Dubai Financial Services Authority), DIFC (Dubai International Financial Center), CNMV (Comisión Nacional del Mercado de Valores), KNF (Komisja Nadzoru Finansowego), IFSC (Belize International Financial Services Commission license number IFSC/60/413/TS/19) | Financial Services Commission (FSC), Cyprus Securities and Exchange Commission (CySEC), Australian Securities and Investments Commission (ASIC) | Financial Conduct Authority (FCA), Australian Securities and Investments Commission (ASIC), Cyprus Securities and Exchange Commission (CySEC), Federal Financial Supervisory Authority (BaFin), Dubai Financial Services Authority (DFSA), Capital Markets Authority of Kenya (CMA), Pepperstone Markets Limited is incorporated in The Bahamas (number 177174 B), Licensed by the Securities Commission of the Bahamas (SCB) number SIA-F217 | Australian Securities and Investments Commission (ASIC), ASIC (406684), Financial Services Authority (FSA), South African Financial Sector Conduct Authority (FSCA), Financial Stability Board (FSB), The Financial Services Agency (JAPAN FSA), Financial Futures Association of Japan (FFAJ), Abu Dhabi Global Markets (ADGM), Financial Regulatory Services Authority (FRSA), Polish Financial Supervision Authority (KNF), Israel Securities Association (ISA), British Virgin Islands Financial Services Commission (BVI), BVI (SIBA/L/13/1049), Central Bank of Ireland | Australian Securities and Investments Commission (ASIC), Cyprus Securities and Exchange Commission (CySEC), FSCA (FSP Number 50926), Capital Markets Authority (CMA), Securities Commission of the Bahamas (SCB) | Cyprus Securities and Exchange Commission (CySEC), Australian Securities and Investments Commission (ASIC), Financial Services Authority (FSA), British Virgin Islands Financial Services Commission (BVI) | Financial Conduct Authority (FCA) | Financial Conduct Authority (FCA), Cyprus Securities and Exchange Commission (CySEC), Financial Sector Conduct Authority (FSCA), Securities Commission of the Bahamas (SCB) |
Min Deposit | 200 | 10 | 100 | No minimum deposit | 5 | 200 | 100 | 100 | 100 | 1 | 100 |
Funding |
|
|
|
|
|
|
|
|
|
|
|
Used By | 180,000+ | 1,000,000+ | 30,000,000+ | 935,000+ | 10,000,000+ | 400,000+ | 300,000+ | 10,000+ | 142,500+ | 10,000+ | 1,866,000+ |
Benefits |
|
|
|
|
|
|
|
|
|
|
|
Accounts |
|
|
|
|
|
|
|
|
|
|
|
Platforms | MT4, MT5, Mirror Trader, Web Trader, cTrader, Windows, Mac, iOS, Android | MT4, MT5, Mac, Web Trader, Tablet & Mobile apps | Web Trader, Tablet & Mobile apps | MT4, Mirror Trader, Web Trader, Tablet & Mobile apps | MT4, MT5, Mac, Web Trader, Tablet & Mobile apps | MT4, MT5, TradingView, DupliTrade, myFXbook, Mac, Web Trader, cTrader, Tablet & Mobile apps | Web Trader, MT4, MT5, AvaTradeGo, AvaOptions, DupliTrade, ZuluTrade, Mobile Apps, ZuluTrade, DupliTrade, MQL5 | MT4, MT5, IRESS, Mac, Web Trader, Tablet & Mobile apps | MT4, MT5, Web Trader, TradingView, Tablet & Mobile apps | Web Trader, Tablet & Mobile apps | MT4, MT5, cTrader, Tablet & Mobile apps |
Support |
|
|
|
|
|
|
|
|
|
|
|
Learn More |
Sign
Up with icmarkets |
Sign
Up with roboforex |
Sign
Up with etoro |
Sign
Up with xtb |
Sign
Up with xm |
Sign
Up with pepperstone |
Sign
Up with avatrade |
Sign
Up with fpmarkets |
Sign
Up with easymarkets |
Sign
Up with spreadex |
Sign
Up with fxpro |
Risk Warning | Losses can exceed deposits | Losses can exceed deposits | 76% of retail investor accounts lose money when trading CFDs with this provider. | 76-85% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 72.89% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | 74-89 % of retail investor accounts lose money when trading CFDs | 71% of retail investor accounts lose money when trading CFDs with this provider | Losses can exceed deposits | Your capital is at risk | Losses can exceed deposits | 75.78% of retail investor accounts lose money when trading CFDs and Spread Betting with this provider |
Demo |
IC Markets Demo |
Roboforex Demo |
eToro Demo |
XTB Demo |
XM Demo |
Pepperstone Demo |
AvaTrade Demo |
FP Markets Demo |
easyMarkets Demo |
SpreadEx Demo |
FxPro Demo |
Excluded Countries | US, IR, CA, NZ, JP | AU, BE, BQ, BR, CA, CW, CZ, DE, ES, EE, EU, FM, FR, FI, GW, ID, IR, JP, LR, MP, NL, PF, PL, RU, SE, SJ, SS, SL, SI, TL, TR, DO, US, IT, AT, PT, BG, HR, CY, DK, FL, GR, IE, LV, LT, MT, RO, SK, CH | ZA, ID, IR, KP, BE, CA, JP, SY, TR, IL, BY, AL, MD, MK, RS, GN, CD, SD, SA, ZW, ET, GH, TZ, LY, UG, ZM, BW, RW, TN, SO, NA, TG, SL, LR, GM, DJ, CI, PK, BN, TW, WS, NP, SG, VI, TM, TJ, UZ, LK, TT, HT, MM, BT, MH, MV, MG, MK, KZ, GD, FJ, PT, BB, BM, BS, AG, AI, AW, AX, LB, SV, PY, HN, GT, PR, NI, VG, AN, CN, BZ, DZ, MY, KH, PH, VN, EG, MN, MO, UA, JO, KR, | US, IN, PK, BD, NG , ID, BE, AU | US, CA, IL, IR | AF, AS, AQ, AR, AM, AZ, BY, BE, BZ, BT, BA, BI, CM, CA, CF, TD, CG, CI, ER, GF, PF, GP, GU, GN, GW, GY, HT, VA, IR, IQ, JP, KZ, LB, LR, LY, ML, MQ, YT, MZ, MM, NZ, NI, KP, PS, PR, RE, KN, LC, VC, WS, SO, GS, KR, SS, SD, SR, SY, TJ, TN, TM, TC, US, UY, VU, VG, EH, ES, YE, ZW, ET | BE, BR, KP, NZ, TR, US, CA, SG | US, JP, NZ | US, IL, BC, MB, QC, ON, AF, BY, BI, KH, KY, TD, KM, CG, CU, CD, GQ, ER, FJ, GN, GW, HT, IR, IQ, LA, LY, MZ, MM, NI, KP, PW, PA, RU, SO, SS, SD, SY, TT, TM, VU, VE, YE | US, TR | US, CA, IR |
You can compare Pharmaceutical Shares Trading Platform ratings, min deposits what the the broker offers, funding methods, platforms, spread types, customer support options, regulation and account types side by side.
We also have an indepth Top Pharmaceutical Shares Trading Platform for 2024 article further below. You can see it now by clicking here
We have listed top Pharmaceutical shares trading platform below.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Past performance is not an indication of future results. Trading history presented is less than 5 complete years and may not suffice as basis for investment decision.
Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.
Cryptoasset investing is highly volatile and unregulated in some EU countries. No consumer protection. Tax on profits may apply.
Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.